Table 1 Clinical and epidemiological characteristics of the included patients (n = 52)
Characteristics | Overalln = 52 (%) | 3D ablation n = 34 (%) | Antiarrhythmic n = 18 (%) | p value |
|---|---|---|---|---|
Age (years), median (IQR) | 49 (24.5–60.0) | 32 (21–54) | 59.5 (54–61) | 0.001 |
Sex | ||||
Male | 23 (44.2) | 17 (50.0) | 6 (33.0) | 0.380 |
Female | 29 (55.8) | 17 (50.0) | 12 (67.0) | |
Region of origin | ||||
Lima (capital of Peru) | 29 (55.8) | 18 (52.9) | 11 (61.1) | 0.770 |
Other provinces | 23 (44.2) | 16 (47.1) | 7 (38.9) | |
Type of arrhythmia | ||||
Focal idiopathic VE/VT | 36 (69.2) | 20 (58.8) | 16 (88.9) | 0.031 |
VE/VT - conduction or fascicular system | 16 (30.8) | 14 (41.2) | 2 (11.1) | |
Symptoms after intervention | ||||
Asymptomatic | 28 (53.8) | 28 (80.0) | 0 (0.0) | < 0.001 |
Symptomatic | 24 (46.2) | 6 (20.0) | 18 (100.0) | |
Symptoms (n = 24)1 | ||||
Palpitations | 22 (91.7) | 5 (83.3) | 17 (94.4) | < 0.001 |
Dyspnoea | 6 (25.0) | 0 (0) | 6 (33.3) | |
Chest pain | 3 (12.5) | 1 (16.7) | 2 (11.1) | |
Syncope | 1 (4.2) | 1 (16.7) | 0 (0.0) | |
Adverse effects/complications | 4 (7.7) | 0 (0.0) | 4 (22.2) | 0.011 |
Recurrence | 14 (26.9) | 5 (14.7) | 9 (50.0) | 0.010 |
Number of external consultations, median (IQR) | - | 3 (2–3) | 14.5 (12–20) | < 0.001 |